These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17867897)

  • 41. Evidence-based prevention: increasing the efficiency of HIV intervention trials.
    Padian NS
    J Infect Dis; 2004 Aug; 190(4):663-5. PubMed ID: 15272391
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of cardiovascular risk in HIV positive patients in a specialized center at Santiago, Chile].
    Lazcano C; Millacura JC; Saavedra F; Cortés CP
    Rev Chilena Infectol; 2016 Jun; 33(3):352-4. PubMed ID: 27598289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular disease in patients with chronic human immunodeficiency virus infection.
    Escárcega RO; Franco JJ; Mani BC; Vyas A; Tedaldi EM; Bove AA
    Int J Cardiol; 2014 Jul; 175(1):1-7. PubMed ID: 24798779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipodystrophic syndrome of HIV and associated factors: a study in a university hospital.
    Silva LLG; Santos EMD; Nascimento LCPD; Cavalcanti MCF; Arruda IKG; Luz MCL; Cabral PC
    Cien Saude Colet; 2020 Mar; 25(3):989-998. PubMed ID: 32159668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV and cardiovascular risk.
    Moyle G; Randell P
    Clin Med (Lond); 2008 Jun; 8(3):315-8. PubMed ID: 18624046
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prevalence, associated and predisposing factors of metabolic syndrome among people living with HIV on antiretroviral treatment in Porto Novo in 2014].
    Adébayo A; Albert DC; Ericie S; Angelo AC; Jules G; Armand W; Séraphin A; Léopold C; Gabriel A
    Pan Afr Med J; 2015; 22():296. PubMed ID: 26966492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management.
    Satapathy SK; Charlton MR
    Liver Transpl; 2011 Jan; 17(1):1-6. PubMed ID: 21254337
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiovascular disease and differences between the sexes.
    Johnson BE; Johnson CA
    Am Fam Physician; 2001 Apr; 63(7):1290, 1292. PubMed ID: 11310645
    [No Abstract]   [Full Text] [Related]  

  • 49. HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.
    Teer E; Essop MF
    Physiology (Bethesda); 2018 Jan; 33(1):74-82. PubMed ID: 29212894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HIV-associated lipodystrophy syndrome. Diagnosis, prevalence, pathogenesis and metabolic complications].
    Haugaard SB; Hansen BR; Madsbad S; Iversen J; Nielsen JO; Andersen O
    Ugeskr Laeger; 2003 Oct; 165(44):4215-8. PubMed ID: 14621553
    [No Abstract]   [Full Text] [Related]  

  • 51. Cardiovascular pathology in AIDS.
    Klatt EC
    Adv Cardiol; 2003; 40():23-48. PubMed ID: 14533545
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of growth hormone-releasing factor in HIV-infected patients.
    Malgarini RB; Pimpinella G
    N Engl J Med; 2008 Feb; 358(9):969; author reply 969-70. PubMed ID: 18305274
    [No Abstract]   [Full Text] [Related]  

  • 53. ART and cardiovascular-disease risk in people with HIV.
    Malvestutto C
    Lancet HIV; 2023 Dec; 10(12):e760-e761. PubMed ID: 38040474
    [No Abstract]   [Full Text] [Related]  

  • 54. [Reconstructive surgery of lipodystrophy secondary to HIV treatments].
    Levan P
    Soins Pediatr Pueric; 2007 Jun; (236):33-6. PubMed ID: 17649923
    [No Abstract]   [Full Text] [Related]  

  • 55. HIV and noncommunicable diseases: the Asian perspective.
    Ananworanich J; Avihingsanon A
    J Acquir Immune Defic Syndr; 2014 Sep; 67 Suppl 1():S99-103. PubMed ID: 25117967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cerebellar atrophy in a HIV/AIDS patient].
    Corti M; Villafañe MF; Palmieri O
    Rev Clin Esp; 2007 Feb; 207(2):103-4. PubMed ID: 17397579
    [No Abstract]   [Full Text] [Related]  

  • 57. Patient subpopulations with elevated cardiovascular risk pose unique treatment challenges.
    L'Italien GJ
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):605-7. PubMed ID: 17081082
    [No Abstract]   [Full Text] [Related]  

  • 58. Managing drug interactions in HIV-infected adults with comorbid illness.
    Hughes CA; Tseng A; Cooper R
    CMAJ; 2015 Jan; 187(1):36-43. PubMed ID: 25225224
    [No Abstract]   [Full Text] [Related]  

  • 59. Daily steps count toward health.
    Mayo Clin Health Lett; 2011 Jan; 29(1):4. PubMed ID: 21341420
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevalence and determinant factors to lipid abnormalities among HIV-infected patients: a cross-sectional study of 812 patients.
    Signorini DJ; Monteiro MC; Signorini DH; Eyer-Silva WA
    Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):583. PubMed ID: 20857066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.